SPC159
Alemtúsúmab
Status:
VeittApplication date:
30.5.2016Application published:
15.6.2016Grant published:
15.8.2017
Max expiry date:
15.9.2028Medicine name:
LemtradaMedicine for children:
No
Timeline
Today
30.5.2016Application
15.6.2016Publication
15.8.2017Registration
15.9.2028Expires
Marketing license
IS authorization number:
EU/1/13/869/001Date:
23.9.2013
Foreign authorization number:
EU/1/13/869Date:
12.9.2013
Owner
Name:
Alcafleu Management GmbH & Co. KGAddress:
Lilienthalstrasse 4, Schönefeld OT Waltersdorf DE
Name:
Genzyme CorporationAddress:
500 Kendall Street, Cambridge US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2066352